Trials & Tribulations Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation July 31, 2026Vol.52 No.30By Zachary S. Buchwald and Michael C. Lowe
Trials & Tribulations Saving Western Kenya’s pediatric blood cancer patientsHow flow cytometry is changing the diagnostic landscape July 10, 2026Vol.52 No.27By Samuel (Tony) Boova, Eda Holl, LaToya Montgomery, Steve Kussick, Nicholas Kigen, Gilbert Olbara, Festus Muigai Njuguna, Terry Vik and Teresa Loile Lotodo
Trials & Tribulations The challenge of making the move from conversational AI to autonomous scientific discoveryAdvancing from level II to level III AI agents in precision medicine July 10, 2026Vol.52 No.27By Enrique Velazquez-Villarreal
FreeTrials & Tribulations Is it time to re-assess the practice and practicality of screening colonoscopy?Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives July 02, 2026Vol.52 No.26By Paul J. Limburg
FreeTrials & Tribulations More than 50 million Americans remain unscreened for colon cancerNew guidelines offer another option July 02, 2026Vol.52 No.26By AmirAli Talasaz
Trials & Tribulations What NHS-Galleri taught us—and what it didn’t June 18, 2026Vol.52 No.24By Scott D. Ramsey and Ruth Etzioni
Trials & Tribulations The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies June 18, 2026Vol.52 No.24By Bryan Bassig, Catherine R. Marinac, David M. Routman, Elizabeth K. O'Donnell, Jennifer Keating Litton, Karthik V. Giridhar, Kennedy Ng Yao Yi, Kurt Giles, Nima Nabavizadeh, Ora K. Gordon, Rebecca Kaltman and Shawn Kothari
FreeTrials & Tribulations Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy June 12, 2026Vol.52 No.23By Peter F. Garrett
Trials & Tribulations The story of daraxonrasib is the ultimate hero’s journeyA narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe June 05, 2026Vol.52 No.22By W. Kimryn Rathmell
Trials & Tribulations As rural cancer disparities persist, aligning policy with care delivery models can close the gap May 29, 2026Vol.52 No.21By Matthew L. Anderson
